Delivery Order SPE2DB22D3301-SPE2DB25FY8DL
- Not listed
- The Defense Logistics Agency awarded a $10,567.60 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of 120-count units of Lynparza 150 mg tablets, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Lynparza is a prescription oncology medication used in cancer treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of LYNPARZA 100 mg tablets (120-count units) with a ceiling value of $10,519.62. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. LYNPARZA is an oncology pharmaceutical used in cancer treatment,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp for the supply of Lynparza (olaparib) 150 mg tablets in quantities of 120 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 4, 2025. The contract was awarded on July 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lynparza...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,519.62 for 120 tablets of Lynparza 100 mg on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a $10,519.62 delivery order to AmerisourceBergen Drug Corp for Lynparza 100 mg tablets (120-count units) with a completion date of August 26, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120 count) valued at $10,567.60 under a firm fixed-price contract. The award was made on September 17, 2025, with an ultimate completion date of October 8, 2025. No set-aside designation was used for this procurement, indicating the award was made through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $10,567.60 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 150 mg, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and reflects a routine pharmaceutical procurement supporting military and federal healthcare operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $42,078.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 100 mg, with an ultimate completion date of August 29, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement. The contract was awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a $42,270.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units) on August 12, 2025, with an ultimate completion date of September 3, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8DLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp for the supply of Lynparza 100 mg tablets (120 count) with a firm fixed price structure. This non-competitive delivery order, issued on July 21, 2025, is set to be completed by August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Lynparza is a specialized oncology medication used in cancer treatment, reflecting DLA's role in procuring critical pharmaceutical products for military and federal healthcare systems. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. The company's federal contract awards demonstrate consistent capability in meeting competitive procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to ensure reliable pharmaceutical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 7/21/25 |